longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

MiniMed

MMED

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -19.74, below the reasonable range, cheaper than 80% of the time in the past 1 years, and the industry ranks 39/45, the industry Median -0.41.

-19.74xP/E
$22.03Stock price
$-1.12Earnings per share
-19.74xP/E
Stock price$22.03Earnings per share$-1.12

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-14.28x
Typical range
-19.72x–-11.58x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
016324864

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
MMEDUSMiniMed
-19.74x146.64%$6.20B
BLCOUSBausch + Lomb
-35.03x94.03%$5.99B
NEOGUSNeogen
-354.13x316.68%$2.80B
ESTAUSEstablishment Labs
-53.30x30.16%$2.07B
XRAYUSDentsply Sirona
-3.42x113.34%$1.87B
KIDSUSOrthopediatrics
-14.31x27.74%$568.67M
CERSUSCerus
-79.03x56.25%$536.06M
SMTIUSSanara Medtech
-10.04x104.59%$321.40M
OSURUSOraSure Tech
-4.90x29.79%$240.70M
RXSTUSRxSight
-4.71x0.68%$221.28M
ZTEKFUSZENTEK LTD
-7.90x--$59.25M
SKYAUSSkyAI
-0.15x--$59.25M
TELAUSTela Bio
-1.41x17.67%$57.91M
XTNTUSXtant Med
-4.12x477.77%$45.87M
NSPRUSInspireMD
-0.67x--$35.19M
RMTIUSRockwell Medical
-6.09x32.67%$31.88M
RVPUSRetractable Tech
-5.85x--$21.09M
LUCYUSInnovative Eyewear
-1.01x--$7.73M
AIDXUS20/20 Biolabs
-0.85x44.74%$6.02M
CUPRUSCuprina
-3.36x--$12.12M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.